Research has shown that medication-assisted treatment (MAT) – a combination of medication and psychosocial support such as counseling or evidence-based behavioral therapy – can be effective in treating opioid dependency.
The Drug Addiction Treatment Act of 2000 enables physicians to qualify to treat opioid dependency with buprenorphine products if they are:
Physicians can complete an eight-hour training to qualify for a waiver to prescribe and dispense buprenorphine. They must also be able to refer patients to counseling and other services.
You can find educational opportunities for physicians supported by the Substance Abuse and Mental Health Services Administration (SAMHSA). Training options include a course (The Providers Clinical Support System for MAT Self Study at the American Osteopathic Academy of Addiction Medicine) that blends a live 4.25 webinar session with a 3.75 hour online session.
Nurse practitioners and physician assistants can also apply for an MAT waiver if they meet requirements, including 24 hours of training. Get details here.
SAMHSA offers a variety of MAT resources, including:
For Pennsylvania Medical Society resources on the opioid abuse crisis, visit www.pamedsoc.org/OpioidResources.
Thank you for the comment! Your comment must be approved first
You've already submitted a review for this item
Thank you! Your review has been submitted successfully
Login to be able to comment
Comment cannot be empty
Rating is required
You typed the code incorrectly. Please try again